cardurion.comHealthcare / Healthcare softwareFounded: 2017Funding to Date: $499.84MM
Cardurion Pharmaceuticals is a biotechnology company that specializes in the discovery and development of therapies intended for cardiovascular disease. Cardurion Pharmaceuticals was founded in 2017 and is headquartered in Burlington, MA. Striving to address the unique needs of patients suffering from heart disease through novel approaches, the team manages the development and clinical trial stages for patients suffering from chronic heart failure along with related therapies that have broad potential for cardiovascular disease treatment.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cardurion Pharma.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.